Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.7%

1 terminated out of 37 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

8%

3 trials in Phase 3/4

Results Transparency

15%

3 of 20 completed with results

Key Signals

3 with results95% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (11)
P 2 (3)
P 3 (1)
P 4 (2)

Trial Status

Completed20
Unknown7
Recruiting5
Active Not Recruiting2
Not Yet Recruiting2
Terminated1

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT07517939Not Yet RecruitingPrimary

What Are the Predictors of Acute Kidney Injury in Children Admitted to Pediatrics Intensive Care Unit at Assiut University Children Hospital?

NCT07477652Not Yet RecruitingPrimary

What is the Effect of Acute Kidney Injury on Weaning From Mechanical Ventilation in Critically Ill Adult Patients?

NCT07262320Recruiting

Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America

NCT07106151Not ApplicableRecruitingPrimary

Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2

NCT05036616Not ApplicableCompletedPrimary

Separation Versus Integrated Approach in Combining ECMO With CRRT

NCT04216927Phase 3RecruitingPrimary

NO During CPB in Neonates to Reduce Risk of AKI

NCT04351906Not ApplicableCompleted

Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome

NCT04008810Completed

Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease

NCT06596811Active Not RecruitingPrimary

Research on the Risk Warning Model and Prevention Strategies for Acute Kidney Injury Associated With Cyclosporine Based on Explainable Deep Neural Networks and Therapeutic Drug Monitoring

NCT06596798Active Not RecruitingPrimary

Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury

NCT04517630Completed

Renal Biomarkers in AKI and COVID-19

NCT06416761RecruitingPrimary

Genetics in the Progression of Nephropathies

NCT04342975Phase 2CompletedPrimary

Protection From Acute Kidney Injury (AKI) With Basis™ Treatment

NCT04114747Not ApplicableRecruitingPrimary

Renal Physiology During Continuous Renal Replacement Therapy

NCT04564833Phase 2CompletedPrimary

Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery

NCT04530448Phase 4Terminated

Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization

NCT05094154Phase 4Completed

Effect of Antibiotic Choice On ReNal Outcomes (ACORN)

NCT04895384UnknownPrimary

El DORADO STUDY (Evaluation of Delivery of Oxygen on Renal, Arrhythmia and Delirium Outcomes Study)

NCT04788394Completed

Renal Involvement in Hospitalized Children With COVID-19

NCT04112953CompletedPrimary

Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study

Scroll to load more

Research Network

Activity Timeline